Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups

Documenti analoghi

• Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
  di: Alfredo Rivas‐Delgado, et al.
  Pubblicazione: (2024)
• Efficacy and safety of the academic anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma
  di: Núria Martínez‐Cibrián, et al.
  Pubblicazione: (2025)
• Integration of gene mutations in risk prognostication for watch‐and‐wait follicular lymphoma patients initiating first‐line treatment
  di: Tian‐Yuan Xu, et al.
  Pubblicazione: (2025)
• Clonal hematopoiesis dynamics influences long‐term outcomes of follicular lymphoma: Results from FIL FOLL12 trial
  di: Nawar Maher, et al.
  Pubblicazione: (2026)
• Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
  di: Alberto Bavieri, et al.
  Pubblicazione: (2024)